PT2262506E - Suspensões de acetonido de triamcinolona de baixa viscosidade altamente floculadas para injeção intravítrea - Google Patents
Suspensões de acetonido de triamcinolona de baixa viscosidade altamente floculadas para injeção intravítrea Download PDFInfo
- Publication number
- PT2262506E PT2262506E PT97205207T PT09720520T PT2262506E PT 2262506 E PT2262506 E PT 2262506E PT 97205207 T PT97205207 T PT 97205207T PT 09720520 T PT09720520 T PT 09720520T PT 2262506 E PT2262506 E PT 2262506E
- Authority
- PT
- Portugal
- Prior art keywords
- low viscosity
- triamcinolone acetonide
- intravitreal injection
- highly flocculated
- suspensions
- Prior art date
Links
- 238000002347 injection Methods 0.000 title 1
- 239000007924 injection Substances 0.000 title 1
- 239000000725 suspension Substances 0.000 title 1
- 229960002117 triamcinolone acetonide Drugs 0.000 title 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3545908P | 2008-03-11 | 2008-03-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2262506E true PT2262506E (pt) | 2014-06-24 |
Family
ID=40548758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97205207T PT2262506E (pt) | 2008-03-11 | 2009-03-10 | Suspensões de acetonido de triamcinolona de baixa viscosidade altamente floculadas para injeção intravítrea |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US8128960B2 (https=) |
| EP (1) | EP2262506B1 (https=) |
| JP (1) | JP5581227B2 (https=) |
| KR (1) | KR101555293B1 (https=) |
| CN (1) | CN101959519B (https=) |
| AR (1) | AR070824A1 (https=) |
| AU (1) | AU2009223649B2 (https=) |
| BR (1) | BRPI0909630B8 (https=) |
| CA (1) | CA2717605C (https=) |
| CL (1) | CL2009000573A1 (https=) |
| DK (1) | DK2262506T3 (https=) |
| ES (1) | ES2471122T3 (https=) |
| MX (1) | MX2010009974A (https=) |
| PL (1) | PL2262506T3 (https=) |
| PT (1) | PT2262506E (https=) |
| RU (1) | RU2481842C2 (https=) |
| SI (1) | SI2262506T1 (https=) |
| TW (1) | TWI468165B (https=) |
| UY (1) | UY31699A1 (https=) |
| WO (1) | WO2009114521A1 (https=) |
| ZA (1) | ZA201005839B (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070202186A1 (en) | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
| JP5581227B2 (ja) * | 2008-03-11 | 2014-08-27 | アルコン リサーチ， リミテッド | 硝子体内注射のための低粘度、高凝集トリアムシノロンアセトニド懸濁剤 |
| AU2009330517A1 (en) * | 2008-12-22 | 2010-07-01 | Alcon Research, Ltd. | Compositions of topical ocular solutions to deliver effective concentrations of active agent to the posterior segment of the eye |
| JP5996544B2 (ja) | 2010-10-15 | 2016-09-21 | クリアサイド・バイオメディカル・インコーポレーテッドＣｌｅａｒｓｉｄｅ Ｂｉｏｍｅｄｉｃａｌ Ｉｎｃｏｒｐｏｒａｔｅｄ | 眼球アクセス用装置 |
| CN102008488B (zh) * | 2010-11-24 | 2012-10-10 | 广州固志医药科技有限公司 | 一种曲安奈德眼用制剂及其制备方法 |
| AR090775A1 (es) * | 2012-04-23 | 2014-12-03 | Otsuka Pharma Co Ltd | Preparado inyectable |
| MX373894B (es) * | 2012-11-08 | 2020-07-09 | Clearside Biomedical Inc | Métodos y dispositivos para el tratamiento de trastornos oculares en sujetos humanos. |
| BR112015027762A2 (pt) | 2013-05-03 | 2017-08-29 | Clearside Biomedical Inc | Aparelho e métodos para injeção ocular |
| WO2014197317A1 (en) | 2013-06-03 | 2014-12-11 | Clearside Biomedical, Inc. | Apparatus and methods for drug delivery using multiple reservoirs |
| EP3157598A4 (en) | 2014-06-20 | 2018-05-16 | Clearside Biomedical, Inc. | Variable diameter cannula and methods for controlling insertion depth for medicament delivery |
| US9694145B1 (en) | 2016-03-29 | 2017-07-04 | Joseph Onorato | Auto-injector systems and method for delivering cyst medication on demand |
| EP3452165A1 (en) | 2016-05-02 | 2019-03-13 | Clearside Biomedical, Inc. | Systems and methods for ocular drug delivery |
| IL305537B2 (en) | 2016-08-12 | 2025-02-01 | Clearside Biomedical Inc | Devices and methods for adjusting the insertion depth of a needle for administering a drug |
| US12090294B2 (en) | 2017-05-02 | 2024-09-17 | Georgia Tech Research Corporation | Targeted drug delivery methods using a microneedle |
| AU2019207515B2 (en) * | 2018-01-10 | 2024-11-14 | Eye Co Pty Ltd | Medical device and pharmaceutical composition for treatment of an eye disease or condition |
| USD893715S1 (en) | 2018-11-06 | 2020-08-18 | Joseph Onorato | Measurement guide for a cyst, lesion or skin disorder |
| CA3136814A1 (en) * | 2019-04-16 | 2020-10-22 | Clearside Biomedical, Inc. | Injectable triamcinolone formulations |
| US10814001B1 (en) | 2019-05-06 | 2020-10-27 | Rvl Pharmaceuticals, Inc. | Oxymetazoline compositions |
| CN114010593A (zh) * | 2021-11-23 | 2022-02-08 | 莱默(北京)药业科技有限公司 | 一种曲安奈德混悬注射液及制备方法 |
| CN115969784B (zh) * | 2022-12-26 | 2025-10-21 | 昆明积大制药股份有限公司 | 曲安奈德注射液的制备方法 |
| WO2025114562A1 (en) * | 2023-11-30 | 2025-06-05 | Institut National de la Santé et de la Recherche Médicale | Intravitreal spironolactone suspension |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3962430A (en) * | 1974-08-07 | 1976-06-08 | Merck & Co., Inc. | Sterilization of solid non-electrolyte medicinal agents employing sodium chloride |
| US4370325A (en) * | 1979-03-30 | 1983-01-25 | Dermik Laboratories | Pharmaceutical compositions and method of treatment |
| US4432964A (en) * | 1981-08-24 | 1984-02-21 | Alza Corporation | Topical composition containing steroid in two forms released independently from polymeric carrier |
| US5164190A (en) * | 1990-12-11 | 1992-11-17 | Theratech, Inc. | Subsaturated transdermal drug delivery device exhibiting enhanced drug flux |
| US5770589A (en) | 1993-07-27 | 1998-06-23 | The University Of Sydney | Treatment of macular degeneration |
| WO1996020712A1 (en) | 1994-12-30 | 1996-07-11 | American Home Products Corporation | Clear non-alcoholic hydrocortisone solutions |
| CA2336703A1 (en) | 1998-07-10 | 2000-01-20 | The University Of Sydney | Prophylactic treatments of neovascularisation in macular degeneration |
| AR026073A1 (es) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica acuosa que contiene ciclesonida |
| AUPQ496500A0 (en) | 2000-01-06 | 2000-02-03 | University Of Sydney, The | Kit |
| US6395294B1 (en) | 2000-01-13 | 2002-05-28 | Gholam A. Peyman | Method of visualization of the vitreous during vitrectomy |
| US6656505B2 (en) * | 2000-07-21 | 2003-12-02 | Alpharma Uspd Inc. | Method for forming an aqueous flocculated suspension |
| WO2002015878A1 (fr) * | 2000-08-25 | 2002-02-28 | Senju Pharmaceutical Co., Ltd. | Preparations en suspension aqueuse |
| HRP20040102A2 (en) * | 2001-07-09 | 2004-10-31 | Combinatorx | Combinations for the treatment of inflammatory disorders |
| US20030129242A1 (en) | 2002-01-04 | 2003-07-10 | Bosch H. William | Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer |
| WO2004073607A2 (en) * | 2003-02-20 | 2004-09-02 | Alcon, Inc. | Use of steroids to treat ocular disorders |
| US20040186084A1 (en) | 2003-03-21 | 2004-09-23 | Akorn, Inc. | Triamcinolone formulations and methods for their preparation and use |
| RU2006113593A (ru) * | 2003-09-23 | 2006-08-27 | Алькон, Инк. (Ch) | Препаративные формы триамцинолона ацетонида и анекортава ацетата для инъекций |
| US20050101582A1 (en) | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
| US20060141049A1 (en) | 2003-11-12 | 2006-06-29 | Allergan, Inc. | Triamcinolone compositions for intravitreal administration to treat ocular conditions |
| US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
| US20050169992A1 (en) * | 2003-12-23 | 2005-08-04 | Frank Jao | Methods and dosage forms for increasing solubility of drug compositions for controlled delivery |
| DE602005011928D1 (de) | 2004-01-20 | 2009-02-05 | Allergan Inc | Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure |
| US20050244469A1 (en) | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Extended therapeutic effect ocular implant treatments |
| US20070225727A1 (en) | 2004-05-31 | 2007-09-27 | Keiichi Matsuhisa | Transparent Tissue-Visualizng Preparation |
| US8246949B2 (en) | 2004-10-27 | 2012-08-21 | Aciont, Inc. | Methods and devices for sustained in-vivo release of an active agent |
| AU2005306309A1 (en) | 2004-11-17 | 2006-05-26 | Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services | Steroid formulation and methods of treatment using same |
| EP1867334A4 (en) | 2005-02-18 | 2009-07-15 | Santen Pharmaceutical Co Ltd | METHOD FOR RELIEVING OR AVOIDING A SECONDARY EFFECT OF A STEROID COMPOUND |
| US7893040B2 (en) * | 2005-07-22 | 2011-02-22 | Oculis Ehf | Cyclodextrin nanotechnology for ophthalmic drug delivery |
| ITRM20050547A1 (it) | 2005-11-04 | 2007-05-05 | Sooft Italia S R L | Gel oftalmico composto da triamcinolone acetonide e da un polimero poliacrilico. |
| JP5581227B2 (ja) * | 2008-03-11 | 2014-08-27 | アルコン リサーチ， リミテッド | 硝子体内注射のための低粘度、高凝集トリアムシノロンアセトニド懸濁剤 |
-
2009
- 2009-03-10 JP JP2010550813A patent/JP5581227B2/ja active Active
- 2009-03-10 PL PL09720520T patent/PL2262506T3/pl unknown
- 2009-03-10 MX MX2010009974A patent/MX2010009974A/es active IP Right Grant
- 2009-03-10 KR KR1020107022609A patent/KR101555293B1/ko active Active
- 2009-03-10 PT PT97205207T patent/PT2262506E/pt unknown
- 2009-03-10 ES ES09720520.7T patent/ES2471122T3/es active Active
- 2009-03-10 BR BRPI0909630A patent/BRPI0909630B8/pt active IP Right Grant
- 2009-03-10 UY UY31699A patent/UY31699A1/es not_active Application Discontinuation
- 2009-03-10 AU AU2009223649A patent/AU2009223649B2/en active Active
- 2009-03-10 CN CN2009801076823A patent/CN101959519B/zh active Active
- 2009-03-10 DK DK09720520.7T patent/DK2262506T3/da active
- 2009-03-10 SI SI200930950T patent/SI2262506T1/sl unknown
- 2009-03-10 CA CA2717605A patent/CA2717605C/en active Active
- 2009-03-10 EP EP09720520.7A patent/EP2262506B1/en active Active
- 2009-03-10 RU RU2010141542/15A patent/RU2481842C2/ru active
- 2009-03-10 WO PCT/US2009/036652 patent/WO2009114521A1/en not_active Ceased
- 2009-03-10 US US12/401,168 patent/US8128960B2/en active Active
- 2009-03-10 TW TW98107670A patent/TWI468165B/zh active
- 2009-03-11 AR ARP090100862A patent/AR070824A1/es unknown
- 2009-03-11 CL CL2009000573A patent/CL2009000573A1/es unknown
-
2010
- 2010-08-16 ZA ZA2010/05839A patent/ZA201005839B/en unknown
-
2012
- 2012-01-17 US US13/352,043 patent/US20120115829A1/en not_active Abandoned
- 2012-01-17 US US13/352,009 patent/US8211880B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201005839B (en) | Low viscosity,highly flocculated triamcinolone acetonide suspensions for intravitreal injection | |
| IL212919A0 (en) | Low viscosity highly concentrated suspensions | |
| EP2282735A4 (en) | COMPOUNDS, COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF | |
| IL212070A0 (en) | 7-piperidinoalkyl-3,4-dihydroquinolone derivative | |
| GB0725321D0 (en) | Delivery vehicles | |
| AP2011005725A0 (en) | Lactams as beta secretase inhibitors. | |
| IL216865A0 (en) | Aptamer for chymase, compositions comprising the same and uses thereof | |
| SI2356123T1 (sl) | Piro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo(e)azuleni | |
| ZA201100797B (en) | Electrodepositable composition | |
| EP2403896A4 (en) | POLYAMIDE OF LIGHT VISCOSITY | |
| GB0812513D0 (en) | Delivery vehicle | |
| AP2011005732A0 (en) | 3-aminocyclopentanecarboxamides as chemokine receptor modulators. | |
| ITRM20070080A1 (it) | Lieviti per spumantizzazione. | |
| PL2172383T3 (pl) | Korytarz przejścia wewnętrznego pomiędzy dwoma pojazdami | |
| GB0809709D0 (en) | Dunhill car,2093 | |
| GB0813815D0 (en) | Corcost Pre 1001,10 | |
| IL188627A0 (en) | Classified-lahaim.com | |
| AU3841P (en) | Passion Ptilotus nobilis | |
| GB0810164D0 (en) | Wedge-dek, shower-floor gradient-former | |
| AP00176S1 (en) | Bottle. | |
| GB0819226D0 (en) | New rail (N.R.) | |
| HK1149266A (en) | Trpa1 antagonists | |
| HK1146533A (en) | Trpa1 antagonists | |
| AU2008906512A0 (en) | Capping element | |
| GB0808831D0 (en) | . |